Go Pro

Ieq Capital LLC Makes New Investment in Cigna Group $CI

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Ieq Capital LLC purchased 39,713 Cigna shares during the second quarter, valued at approximately $10.95 million. Institutional investors collectively own 86.99% of the company.
  • Cigna reported quarterly EPS of $7.78, exceeding analyst expectations of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company reaffirmed fiscal 2026 EPS guidance of approximately $30.45.
  • The company declared a quarterly dividend of $1.56 per share, representing an annualized payout of $6.24 and a 2.3% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $339.45.
  • Interested in Cigna Group? Here are five stocks we like better.

Ieq Capital LLC purchased a new position in shares of Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 39,713 shares of the health services provider's stock, valued at approximately $10,948,000.

Other hedge funds have also made changes to their positions in the company. Norges Bank bought a new stake in Cigna Group during the fourth quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider's stock worth $900,912,000 after buying an additional 3,141,844 shares during the last quarter. Dodge & Cox lifted its stake in shares of Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock worth $3,065,681,000 after buying an additional 1,833,389 shares during the last quarter. Boston Partners boosted its holdings in shares of Cigna Group by 314.6% during the 4th quarter. Boston Partners now owns 1,638,191 shares of the health services provider's stock worth $450,856,000 after buying an additional 1,243,056 shares during the period. Finally, GQG Partners LLC boosted its holdings in shares of Cigna Group by 14.3% during the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider's stock worth $2,136,699,000 after buying an additional 972,302 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Activity

In other news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the business's stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,012 shares of company stock worth $6,386,550 over the last 90 days. Corporate insiders own 0.60% of the company's stock.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $276.19 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The firm has a fifty day moving average price of $284.20 and a two-hundred day moving average price of $281.38. The company has a market cap of $72.98 billion, a PE ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period last year, the business posted $7.20 EPS. The business's quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group's dividend payout ratio (DPR) is 25.82%.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Raymond James Financial downgraded shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and dropped their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. UBS Group raised their price target on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, May 22nd. Jefferies Financial Group lowered Cigna Group from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Wolfe Research restated an "outperform" rating and set a $315.00 target price on shares of Cigna Group in a research note on Tuesday, June 16th. Finally, Guggenheim raised their target price on Cigna Group from $338.00 to $361.00 and gave the company a "buy" rating in a report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $339.45.

Read Our Latest Stock Analysis on Cigna Group

Cigna Group Company Profile

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines